173 related articles for article (PubMed ID: 20810246)
21. Role of Toll-like receptors in primary Sjögren's syndrome with a special emphasis on B-cell maturation within exocrine tissues.
Guerrier T; Le Pottier L; Devauchelle V; Pers JO; Jamin C; Youinou P
J Autoimmun; 2012 Aug; 39(1-2):69-76. PubMed ID: 22357449
[TBL] [Abstract][Full Text] [Related]
22. Increased expression of the B-cell-regulatory molecule CD72 in primary Sjögren's syndrome.
Smith AJ; Gordon TP; Macardle PJ
Tissue Antigens; 2004 Mar; 63(3):255-9. PubMed ID: 14989715
[TBL] [Abstract][Full Text] [Related]
23. [Cell-mediated immunity in patients with Sjogren's syndrome].
Krejsek J; Slezák R; Kopecký O; Vokurková D; Loudová M; Derner V
Cas Lek Cesk; 1997 Jan; 136(2):44-7. PubMed ID: 9147852
[TBL] [Abstract][Full Text] [Related]
24. CD27 expression by a distinct subpopulation of human B lymphocytes.
Maurer D; Holter W; Majdic O; Fischer GF; Knapp W
Eur J Immunol; 1990 Dec; 20(12):2679-84. PubMed ID: 1702722
[TBL] [Abstract][Full Text] [Related]
25. Immunohistologic analysis of lymphoid infiltrates in primary Sjogren's syndrome using monoclonal antibodies.
Adamson TC; Fox RI; Frisman DM; Howell FV
J Immunol; 1983 Jan; 130(1):203-8. PubMed ID: 6600176
[TBL] [Abstract][Full Text] [Related]
26. Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome.
Daridon C; Devauchelle V; Hutin P; Le Berre R; Martins-Carvalho C; Bendaoud B; Dueymes M; Saraux A; Youinou P; Pers JO
Arthritis Rheum; 2007 Apr; 56(4):1134-44. PubMed ID: 17393395
[TBL] [Abstract][Full Text] [Related]
27. Major immunoglobulin capping deficiency in the peripheral blood B cells of patients with Sjögren's syndrome.
Bataille R; Zhang XG; Duperray C; Rajzbaum G; Brochier J; Klein B
Immunology; 1992 Mar; 75(3):550-2. PubMed ID: 1572701
[TBL] [Abstract][Full Text] [Related]
28. Low number of memory B cells in the salivary glands of patients with primary Sjögren's syndrome.
Aqrawi LA; Brokstad KA; Jakobsen K; Jonsson R; Skarstein K
Autoimmunity; 2012 Nov; 45(7):547-55. PubMed ID: 22849322
[TBL] [Abstract][Full Text] [Related]
29. [Immunohistochemical study of inflammatory infiltrates in minor salivary glands in Sjögren's syndrome and other autoimmune diseases].
Tomás S; Coll J; Reth P; Corominas JM
Med Clin (Barc); 1998 Nov; 111(18):681-6. PubMed ID: 9887430
[TBL] [Abstract][Full Text] [Related]
30. Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjögren's syndrome.
Kobayashi M; Kawano S; Hatachi S; Kurimoto C; Okazaki T; Iwai Y; Honjo T; Tanaka Y; Minato N; Komori T; Maeda S; Kumagai S
J Rheumatol; 2005 Nov; 32(11):2156-63. PubMed ID: 16265694
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic dysregulation in salivary glands from patients with primary Sjögren's syndrome may be ascribed to infiltrating B cells.
Thabet Y; Le Dantec C; Ghedira I; Devauchelle V; Cornec D; Pers JO; Renaudineau Y
J Autoimmun; 2013 Mar; 41():175-81. PubMed ID: 23478041
[TBL] [Abstract][Full Text] [Related]
32. Abnormal B cell differentiation in primary Sjögren's syndrome results in a depressed percentage of circulating memory B cells and elevated levels of soluble CD27 that correlate with Serum IgG concentration.
Bohnhorst JØ; Bjørgan MB; Thoen JE; Jonsson R; Natvig JB; Thompson KM
Clin Immunol; 2002 Apr; 103(1):79-88. PubMed ID: 11987988
[TBL] [Abstract][Full Text] [Related]
33. Expression of MHC class II antigens and other T cell activation antigens on T cells and salivary duct epithelial cells in the salivary gland of cases of Sjögren's syndrome.
Takaya M; Ichikawa Y; Shimizu H; Uchiyama M; Moriuchi J; Arimori S
Tokai J Exp Clin Med; 1990 Mar; 15(1):27-33. PubMed ID: 2087703
[TBL] [Abstract][Full Text] [Related]
34. Lymphocyte subsets in Sjogren's syndrome: a quantitative analysis using monoclonal antibodies and the fluorescence-activated cell sorter.
Bakhshi A; Miyasaka N; Kavathas P; Daniels TE; Strand CV; Herzenberg LA; Talal N
J Clin Lab Immunol; 1983 Feb; 10(2):63-9. PubMed ID: 6601716
[TBL] [Abstract][Full Text] [Related]
35. Expression of proteasomal immunosubunit beta1i is dysregulated in inflammatory infiltrates of minor salivary glands in Sjogren's syndrome.
Morawietz L; Martinez-Gamboa L; Scheffler S; Hausdorf G; Dankof A; Kuckelkorn U; Doerner T; Egerer K; Burmester GR; Faustman DL; Feist E
J Rheumatol; 2009 Dec; 36(12):2694-703. PubMed ID: 19833746
[TBL] [Abstract][Full Text] [Related]
36. In Sjögren's syndrome, B lymphocytes induce epithelial cells of salivary glands into apoptosis through protein kinase C delta activation.
Varin MM; Guerrier T; Devauchelle-Pensec V; Jamin C; Youinou P; Pers JO
Autoimmun Rev; 2012 Feb; 11(4):252-8. PubMed ID: 22001522
[TBL] [Abstract][Full Text] [Related]
37. [Lymphocyte subsets in labial salivary gland of Sjogren's syndrome].
Li X
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1993 Apr; 15(2):83-8. PubMed ID: 8242827
[TBL] [Abstract][Full Text] [Related]
38. T cell subpopulations in the labial minor salivary gland histopathologic lesion of Sjögren's syndrome.
Skopouli FN; Fox PC; Galanopoulou V; Atkinson JC; Jaffe ES; Moutsopoulos HM
J Rheumatol; 1991 Feb; 18(2):210-4. PubMed ID: 1827160
[TBL] [Abstract][Full Text] [Related]
39. Expression of CD5 and CD23 on B cells of patients with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome. Relationship with disease activity and treatment.
Ebo D; DeClerck LS; Bridts CH; Stevens WJ
In Vivo; 1994; 8(4):577-80. PubMed ID: 7534494
[TBL] [Abstract][Full Text] [Related]
40. B cell-targeted therapies in Sjögren's syndrome.
Tobón GJ; Pers JO; Youinou P; Saraux A
Autoimmun Rev; 2010 Feb; 9(4):224-8. PubMed ID: 19671451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
